Heart Health Study

Quick Reference:

What is the purpose of this study?

Where is my nearest study site?

Who can participate?

Who cannot participate?

What is involved? 

Reimbursements

What is the purpose of this study?

This study aims to evaluate the safety and efficacy of an investigational drug that is aimed at reducing the plaque burden within the arteries. 

Where is my nearest study site?

Here is a list of all of the sites who are currently recruiting for this study:

Australia 

• CMAX Clinical Research, Adelaide, South Australia

Who can participate?

To take part in this study, you will need to meet all the following:

• Aged 40-79 (inclusive) 
• Diagnosis of Acute Coronary Syndrome and be at least 12 months post cardiac event 
• BMI between 18 and 34
• Be on a stable medication regime if applicable, with no planned changes during the study period.

Who cannot participate?

Unfortunately, if any of the following apply to you, this study is not the right fit for you:

• Currently pregnant, planning to become pregnant during the study or lactating
• Participated in a clinical trial within the past 3 months
• History of a cancer diagnosis within the past 5 years (excluding non Melanoma Skin Cancer) 
• Cardiac intervention requiring hospitalisation within the past 12 months
• History of or planned coronary artery bypass grafting

Please note, additional eligibility criteria apply and will be discussed in a phone call with our team.

What is involved?

If the study is deemed suitable, your participation is expected to last approximately 28 weeks. This includes: 

• 1 initial screening visit 
• 8 follow up visits

Participation in this research is voluntary, and you may withdraw from the study at any time.

If you take part in the research study, there will be:

• Reimbursement of costs; For out-of-pocket expenses, such as travel and parking.
• Convenience; There are no overnight stays.
• Free study-related medical care; Be among the first to access potential new research treatments before they are widely available.
• Expert medical monitoring; Receive top-tier medical care and monitoring from experienced healthcare professionals.
• Contribution to medical research; Help investigate a potential new treatment that could improve the lives of individuals with heart conditions.
  
  

What is Acute Coronary Syndrome?

Acute Coronary Syndrome is the term given to heart conditions in which supply of blood to the heart is affected causing chest pain/heart events relative to potential blockage*. 

Why is this study important?

The condition that is at risk of becoming Acute Coronary Syndrome is atherosclerosis which is one of the leading causes of mortality across the word. This condition occurs when there is a buildup of plaque in the arteries and can lead to heart conditions associated with blockages.

Who is involved? 

This study is being sponsored by Cyclarity Therapeutics who are located in Novato, California.